Skip to main content
Premium Trial:

Request an Annual Quote

New Next-gen Sequencing Facilities in New York

NEW YORK (GenomeWeb News) – Empire Genomics, the University at Buffalo, and Life Technologies have joined to develop CLIA-certified next-generation sequencing facilities in upstate New York, they announced today.

The facilities will be set up at the UB's New York State Center of Excellence in Bioinformatics and Life Sciences and at the Buffalo, NY, headquarters of Empire Genomics. Life Technologies is providing Ion Torrent sequencers to the facilities.

The technology along with the expertise of UB researchers and Empire Genomics "will help researchers develop new diagnostic tests that, in the future, could enable physicians to prescribe treatments tailored to each individual based on genetic make-up," the three partners said.

Financial and other details of the deal were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.